Scientists have developed micro-robots that can perform non-invasive 3D scans to detect and diagnose colorectal cancer in ...

Vicarious Surgical Inc. (RBOT) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...

A tiny magnetic robot which can take 3D scans from deep within the body, that could revolutionize early cancer detection, has been developed by researchers. The team say this is the first time it has ...

In a report released today, Adam Maeder from Piper Sandler maintained a Hold rating on Vicarious Surgical (RBOT – Research Report), with a price target of $8.50. The company’s shares closed ...